You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

Details for Patent: 7,459,428


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 7,459,428
Title:Method of regulating glucose metabolism, and reagents related thereto
Abstract:One aspect of the present invention relates to a method for treating Type II diabetes in an animal, comprising conjointly administering to the animal metformin and an inhibitor of dipeptidylpeptidase IV or a pharmaceutically acceptable salt thereof in an amount sufficient to treat Type II diabetes of the animal.
Inventor(s): Bachovchin; William W. (Melrose, MA), Plaut; Andrew G. (Lexington, MA), Drucker; Daniel (Toronto, CA)
Assignee: Trustees of Tufts College (Medford, MA) New England Medical Center Hospitals, Inc. (Boston, MA) 1149336 Ontario, Inc. (Toronto, Ontario, CA)
Application Number:11/487,947
Patent Claim Types:
see list of patent claims
Use; Delivery; Composition;
Patent landscape, scope, and claims:

United States Patent 7,459,428: A Detailed Analysis of Scope, Claims, and Patent Landscape

Introduction

The United States Patent 7,459,428, titled "Method of regulating glucose metabolism, and reagents related thereto," is a significant patent in the field of diabetes treatment. This analysis will delve into the scope and claims of the patent, as well as the broader patent landscape surrounding this technology.

Patent Overview

Publication Details

  • Publication Number: US7459428B2
  • Authority: United States
  • Prior Art Date: The patent was filed on June 30, 2006, and granted on November 25, 2008[4].

Scope and Claims

The patent describes a method for treating Type II diabetes in animals, including humans, by conjointly administering specific reagents. The claims include:

  • Methods for regulating glucose metabolism.
  • Use of specific chemical compounds, such as inhibitors and other reagents, to treat diabetes.
  • The patent details various chemical groups, including alkyl, alkenyl, alkynyl, and heterocyclic groups, which are integral to the invention[4].

Key Claims and Descriptions

Method of Treatment

The patent outlines a method for treating Type II diabetes by administering a combination of reagents that regulate glucose metabolism. This includes the use of inhibitors and other chemical compounds to manage insulin resistance and glucose tolerance[4].

Chemical Compounds

The patent specifies various chemical groups and compounds, such as:

  • Alkyl, alkenyl, and alkynyl groups.
  • Heterocyclic groups.
  • Amino acids and their derivatives.
  • Specific examples include metformin and other related compounds[4].

Patent Landscape Analysis

Geographical Spread and Saturation

To understand the patent landscape, it is crucial to analyze the geographical spread and saturation of similar patents.

  • Geographical Spread: Patents related to diabetes treatment are filed globally, with significant contributions from the United States, Europe, Japan, and China. This indicates a broad geographical interest in this technology area[1][3].

  • Saturation: The patent space for diabetes treatments, particularly those involving metabolic regulation, is highly saturated. This saturation suggests that entering this space can be challenging due to the extensive prior art and existing patents. A comprehensive patent landscape analysis would help identify niche areas or alternative technologies that are less saturated[3].

Competitors and New Entrants

  • Competitors: Major pharmaceutical companies and research institutions are key players in this patent space. Companies like Novo Nordisk, Eli Lilly, and Sanofi have significant patent portfolios related to diabetes treatments[3].

  • New Entrants: New entrants into this space often focus on niche technologies or innovative approaches to diabetes treatment. Identifying these new entrants and their focus areas can provide insights into emerging trends and potential collaboration or competition[3].

Time-Slicing and Trends

  • Time-Slicing: Analyzing the patent filings over time can reveal trends and shifts in research focus. For example, a decrease in patent filings in a particular area might indicate a shift towards newer technologies or a saturation point in that area[3].

  • Trends: Current trends in diabetes treatment patents include a focus on personalized medicine, gene therapy, and advanced drug delivery systems. These trends indicate a move towards more targeted and efficient treatments[3].

Tools and Resources for Analysis

USPTO Resources

  • Patent Public Search: This tool provides enhanced access to prior art and is essential for conducting a preliminary patent search. It replaces legacy tools like PubEast and PubWest[1].

  • Global Dossier: This service allows users to access file histories of related applications from participating IP Offices, providing a comprehensive view of the patent family and related data[1].

  • Patent and Trademark Resource Centers (PTRCs): These centers offer local search resources and training in patent search techniques, which can be invaluable for detailed landscape analysis[1].

International Resources

  • European Patent Office (EPO): The EPO's esp@cenet network provides access to Europe's patent databases and machine translations of European patents[1].

  • World Intellectual Property Organization (WIPO): WIPO's PATENTSCOPE ® Search Service offers full-text search of published international patent applications and machine translations for some documents[1].

Strategic Insights from Patent Landscape Analysis

Identifying Niche Areas

A comprehensive patent landscape analysis can help identify underappreciated niche areas within the diabetes treatment space. For instance, a company might focus on a specific type of diabetes or a particular mechanism of action that is less saturated with patents[3].

Counseling Decision-Makers

This analysis provides critical data and insights that can guide company leadership in their decision-making. It helps in assessing the potential rewards or risks of entering a highly saturated patent space and in identifying opportunities for innovation and differentiation[3].

Key Takeaways

  • High Saturation: The patent space for diabetes treatments is highly saturated, making it challenging to secure new patents without thorough landscape analysis.
  • Global Interest: There is significant global interest in this technology area, with major contributions from various countries.
  • Niche Opportunities: Identifying niche areas or alternative technologies can provide opportunities for innovation and differentiation.
  • Strategic Decision-Making: Comprehensive patent landscape analysis is crucial for guiding long-term strategic decisions in research, development, and patent prosecution.

FAQs

What is the main focus of United States Patent 7,459,428?

The main focus of this patent is a method for treating Type II diabetes by conjointly administering specific reagents to regulate glucose metabolism.

How saturated is the patent space for diabetes treatments?

The patent space for diabetes treatments, particularly those involving metabolic regulation, is highly saturated, indicating a challenging environment for new entrants.

What tools are available for conducting a patent landscape analysis?

Tools such as the USPTO's Patent Public Search, Global Dossier, and resources from international IP offices like the EPO and WIPO are essential for conducting a comprehensive patent landscape analysis.

How can a patent landscape analysis help in strategic decision-making?

A patent landscape analysis provides critical data and insights that help in assessing the potential rewards or risks of entering a particular patent space, identifying niche areas, and guiding long-term strategic decisions in research, development, and patent prosecution.

What are some emerging trends in diabetes treatment patents?

Current trends include a focus on personalized medicine, gene therapy, and advanced drug delivery systems, indicating a move towards more targeted and efficient treatments.

Sources

  1. USPTO: Search for patents - USPTO
  2. RPX Insight: Case 1:15-cv-00757-UNA Document 1 Filed 08/28/15
  3. AcclaimIP: Patent Landscape Analysis - Uncovering Strategic Insights
  4. Google Patents: US7459428B2 - Method of regulating glucose metabolism, and reagents related thereto
  5. FDA: ANDA 208472 ANDA TENTATIVE APPROVAL - accessdata.fda.gov

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 7,459,428

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.